시장보고서
상품코드
1149856

심방세동 시장 : 시술별(약물 요법, 비약물 요법), 기술별, 최종사용자별(병원, 전문의, 진료소, 기타), 지역별 - 규모, 점유율, 전망, 기회 분석(2022-2030년)

Atrial Fibrillation Market, by Procedure (Pharmacological, Non-Pharmacological, by Technology, by End User Hospitals, Speciality, Clinics and Others), and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

발행일: | 리서치사: Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

심방세동은 심장의 전기계 장애에 의해 발생하는 심박의 이상에 의해 구별되는 심장 부정맥의 일종입니다. 심방세동은 가장 일반적인 부정맥의 일종으로 생각되고 있습니다. 심장 박동이 느리거나, 빠르거나 불규칙하게 되는 것을 부정맥이라고 부릅니다. 심방세동을 치료하지 않는 경우, 뇌졸중 및 기타 중증의 합병증을 일으킬 가능성이 있습니다. 심방세동은 당뇨병, 고혈압, 기타 심장 질병을 가지고 있는 경우, 위험한 상태가 될 수 있습니다.

목차

제1장 조사 목적과 전제조건

  • 조사 목적
  • 전제조건
  • 약어 설명

제2장 시장의 전망

  • 리포트 내용
    • 시장의 정의와 범위
  • 주요 요약
    • 시장 스냅숏 : 시술별
    • 시장 스냅숏 : 기술별
    • 시장 스냅숏 : 최종사용자별
    • 시장 스냅숏 : 지역별
  • COM(Coherent Opportunity Map)

제3장 시장 역학, 규제, 동향 분석

  • 시장 역학
    • 촉진요인
    • 억제요인
    • 시장 기회
  • 영향 분석
  • 시장 동향
  • 최근 동향
  • 인수와 파트너십 시나리오
  • 기술 개요
  • 법규제 시나리오
  • 파이프라인 분석
  • PEST 분석

제4장 세계의 심방세동 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

  • 전체적인 영향
  • 수급에 대한 영향
  • 시장에 대한 COVID-19의 영향

제5장 세계의 심방세동 시장 : 시술별, 2017-2030년

  • 약리학적
  • 약리학적 방법별
  • 비약리학적

제6장 세계의 심방세동 시장 : 기술별, 2017-2030년

  • 라디오파
  • 레이저
  • 냉동요법
  • 기타

제7장 세계의 심방세동 시장 : 최종사용자별, 2017-2030년

  • 병원
  • 전문 클리닉
  • 기타

제8장 세계의 심방세동 시장 : 지역별, 2017-2030년

  • 북미
  • 미국
  • 캐나다
  • 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
  • 기타 라틴아메리카 지역
  • 유럽
  • 영국
  • 독일
  • 이탈리아
  • 프랑스
  • 스페인
  • 러시아
  • 기타 유럽 지역
  • 아시아태평양
  • 중국
  • 인도
  • 일본
  • ASEAN
  • 호주
  • 한국
  • 기타 아시아태평양
  • 중동 지역
  • GCC
  • 이스라엘
  • 기타 중동 지역
  • 아프리카
  • 북아프리카
  • 중앙아프리카
  • 남아프리카

제9장 경쟁 구도

  • AtriCure, Inc, Inc
  • Biosense Webster
  • Boehringer Ingelheim GmbH
  • Boston Scientific Corporation
  • Bristol-Myers Squibb Corporation
  • CardioFocus, Inc.
  • Endoscopic Technologies, Inc
  • Sanofi Aventis
  • Johnson and Johnson Ltd.
  • Abbott Laboratories
  • Research Methodology
  • About Us
KSA 22.11.21

Atrial fibrillation is a type of cardiac arrhythmia distinguished by an abnormal cardiac rhythm caused by a disturbance in heart's electrical system. It is considered to be one of the most prevalent types of cardiac arrhythmia. When the heart beats too slowly, too quickly, or irregularly, it is called an arrhythmia. Atrial fibrillation if untreated, can lead to a stroke and other serious medical complications. Atrial fibrillation can be dangerous if a person have diabetes, high blood pressure or other diseases of the heart.

Atrial fibrillation may occur in isolated incidents or it may be a chronic illness, fluttering heartbeat, irregular pulse, weakness, dizziness, and fatigue. Atrial fibrillation is mostly brought on by chaotic signals that cause the atria, the two top chambers of your heart, to contract quickly and out of time. Because of how swiftly they contract, the heart's walls fibrillate. Atrial fibrillation may result from electrical system damage to your heart. The signals in the upper chambers of the heart are disorganized in atrial fibrillation. The outcome is a shaking of the higher chambers (quiver). The lower cardiac chambers are then attempted to be reached by the AV node, which is then inundated with impulses (ventricles). A quick and erratic heart rhythm results from this.

Market Dynamics

High consumption of alcohol is also expected to aid in growth of the market. For instance, according to data published on August 2021, on Gallup, Inc, which is an U.S. analytics and advisory company, stated that about 60% of U.S. adults drink alcoholic beverages in 2021.

Key features of the study:

  • This report provides an in-depth analysis of the global atrial fibrillation market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global atrial fibrillation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include AtriCure, Inc., Biosense Webster, Inc., Boehringer Ingelheim GmbH, Boston Scientific Corporation, Bristol-Myers Squibb Corporation, CardioFocus, Inc., Endoscopic Technologies, Inc., Sanofi Aventis, Johnson and Johnson Ltd., and Abbott Laboratories.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global atrial fibrillation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global atrial fibrillation market

Detailed Segmentation:

  • Global Atrial Fibrillation Market, By Procedure:
    • Pharmacological
      • Anti-arrhythmic
      • Anti-coagulant
    • Non-Pharmacological
      • Catheter Ablation Procedures
      • Maze surgery
      • Electric Cardioversion
  • Global Atrial Fibrillation Market, By Technology:
    • Radiofrequency
    • Laser
    • Cryotherapy
    • Others
  • Global Atrial Fibrillation Market, By End User:
    • Hospitals
    • Speciality Clinics
    • Others
  • Global Atrial Fibrillation Market, By Region:
    • North America
      • By Country
    • U.S.
    • Canada
    • Latin America
      • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
      • By Country
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Country
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
      • By Country
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
      • By Region/Country
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • AtriCure, Inc.
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Biosense Webster, Inc
    • Boehringer Ingelheim GmbH
    • Boston Scientific Corporation
    • Bristol-Myers Squibb Corporation
    • CardioFocus, Inc.
    • Endoscopic Technologies, Inc.
    • Sanofi Aventis
    • Johnson and Johnson Ltd
    • Abbott Laboratories

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Procedure
    • Market Snapshot, By Technology
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Recent Developments
  • Acquisitions and Partnerships Scenario
  • Technology Overview
  • Regulatory Scenario
  • Pipeline Analysis
  • PEST Analysis

4. Global Atrial Fibrillation Market- Impact of Coronavirus (Covid-19) Pandemic

  • Overall Impact
  • Impact on Supply and Demand
  • COVID-19 Impact on the market

5. Global Atrial Fibrillation Market, By Procedure, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Pharmacological
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • By Pharmacological
    • Anti-arrhythmic
    • Anti-coagulant
  • Non-Pharmacological
    • Catheter Ablation Procedures,
    • Maze surgery,
    • Electric Cardioversion

6. Global Atrial Fibrillation Market, By Technology, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Radiofrequency
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Laser
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Cryotherapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Atrial Fibrillation Market, By End User, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Hospitals
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Specialty clinics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Atrial Fibrillation Market, By Region, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • AtriCure, Inc, Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Biosense Webster
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Boehringer Ingelheim GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bristol-Myers Squibb Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • CardioFocus, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Endoscopic Technologies, Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sanofi Aventis
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Johnson and Johnson Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Research Methodology
  • About Us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제